General Information of Drug Transporter (DT)
DT ID DTD0002 Transporter Info
Gene Name ABCC2
Transporter Name Multidrug resistance-associated protein 2
Gene ID
1244
UniProt ID
Q92887
Epigenetic Regulations of This DT (EGR)

Methylation

  Pancretic ductal adenocarcinoma

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

5'UTR (cg10264188)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 2.32E-07; Z-score: 1.27E+00

Methylation in Case

5.65E-01 (Median) Methylation in Control 5.00E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS1500 (cg09177518)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.22E+00 Statistic Test p-value: 4.10E-24; Z-score: 4.91E+00

Methylation in Case

2.67E-01 (Median) Methylation in Control 8.30E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS1500 (cg14208112)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.63E+00 Statistic Test p-value: 3.05E-17; Z-score: 3.28E+00

Methylation in Case

1.14E-01 (Median) Methylation in Control 7.02E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS1500 (cg15623519)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.30E+00 Statistic Test p-value: 6.60E-07; Z-score: -2.16E+00

Methylation in Case

2.83E-01 (Median) Methylation in Control 3.69E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg06210630)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.52E-04; Z-score: -7.42E-01

Methylation in Case

5.45E-01 (Median) Methylation in Control 5.71E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg21378238)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 3.61E-03; Z-score: 1.86E-01

Methylation in Case

2.97E-01 (Median) Methylation in Control 2.87E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

1stExon (cg24173049)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.52E+00 Statistic Test p-value: 5.09E-05; Z-score: -1.22E+00

Methylation in Case

1.14E-01 (Median) Methylation in Control 2.88E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg09283154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.87E+00 Statistic Test p-value: 8.12E-16; Z-score: 2.76E+00

Methylation in Case

3.94E-01 (Median) Methylation in Control 2.10E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg15889012)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.37E+00 Statistic Test p-value: 6.34E-08; Z-score: -2.06E+00

Methylation in Case

1.61E-01 (Median) Methylation in Control 2.21E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg11201401)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 7.04E-04; Z-score: 7.93E-01

Methylation in Case

5.28E-01 (Median) Methylation in Control 4.78E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg11805188)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 2.70E-02; Z-score: 7.94E-01

Methylation in Case

4.88E-01 (Median) Methylation in Control 4.30E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.00E-03; Z-score: -2.28E+00

Methylation in Case

7.39E-01 (Median) Methylation in Control 7.83E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

TSS200 (cg09448875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 1.24E-05; Z-score: -2.28E+01

Methylation in Case

6.29E-01 (Median) Methylation in Control 8.27E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg17044311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.92E+00 Statistic Test p-value: 3.57E-13; Z-score: -1.45E+01

Methylation in Case

4.06E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.77E+00 Statistic Test p-value: 2.90E-11; Z-score: -1.73E+01

Methylation in Case

4.73E-01 (Median) Methylation in Control 8.38E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.88E+00 Statistic Test p-value: 1.09E-08; Z-score: -2.14E+01

Methylation in Case

4.49E-01 (Median) Methylation in Control 8.46E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.61E-06; Z-score: -7.42E+00

Methylation in Case

7.31E-01 (Median) Methylation in Control 7.94E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 1.40E-04; Z-score: -2.97E+00

Methylation in Case

7.31E-01 (Median) Methylation in Control 8.15E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.41E-02; Z-score: -1.95E+00

Methylation in Case

7.40E-01 (Median) Methylation in Control 7.86E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

Body (cg08720365)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.42E-02; Z-score: -6.97E-01

Methylation in Case

7.62E-01 (Median) Methylation in Control 7.80E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in bladder cancer [ 2 ]

Location

3'UTR (cg10841077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 8.61E-03; Z-score: -2.36E+00

Methylation in Case

8.94E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in breast cancer [ 3 ]

Location

TSS1500 (cg00826767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 3.34E-07; Z-score: -1.85E+00

Methylation in Case

7.28E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in breast cancer [ 3 ]

Location

TSS200 (cg09448875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 2.55E-08; Z-score: -2.20E+00

Methylation in Case

6.99E-01 (Median) Methylation in Control 7.86E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 3.52E-10; Z-score: -2.13E+00

Methylation in Case

7.26E-01 (Median) Methylation in Control 7.85E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 1.28E-07; Z-score: -1.52E+00

Methylation in Case

6.53E-01 (Median) Methylation in Control 7.60E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg19378330)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.33E+00 Statistic Test p-value: 4.65E-07; Z-score: 1.65E+00

Methylation in Case

9.35E-02 (Median) Methylation in Control 4.01E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 3.30E-05; Z-score: -1.28E+00

Methylation in Case

7.06E-01 (Median) Methylation in Control 8.23E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.38E+00 Statistic Test p-value: 5.66E-05; Z-score: 1.06E+00

Methylation in Case

5.37E-02 (Median) Methylation in Control 3.89E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg25290633)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 9.35E-05; Z-score: -8.82E-01

Methylation in Case

8.52E-01 (Median) Methylation in Control 8.83E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 9.11E-04; Z-score: -7.14E-01

Methylation in Case

7.52E-01 (Median) Methylation in Control 8.38E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg16201095)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 4.02E-03; Z-score: -4.81E-01

Methylation in Case

9.58E-01 (Median) Methylation in Control 9.68E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in breast cancer [ 3 ]

Location

Body (cg17044311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.43E-02; Z-score: -7.52E-01

Methylation in Case

7.89E-01 (Median) Methylation in Control 8.34E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of ABCC2 in breast cancer [ 3 ]

Location

3'UTR (cg10841077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.75E-03; Z-score: -5.33E-01

Methylation in Case

9.08E-01 (Median) Methylation in Control 9.18E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

TSS1500 (cg00826767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.40E-05; Z-score: -9.89E-01

Methylation in Case

8.99E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

TSS1500 (cg16377144)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 4.26E-05; Z-score: -1.18E+00

Methylation in Case

9.03E-01 (Median) Methylation in Control 9.24E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.54E-04; Z-score: -7.53E-01

Methylation in Case

8.88E-01 (Median) Methylation in Control 9.05E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 8.51E-12; Z-score: -2.74E+00

Methylation in Case

7.66E-01 (Median) Methylation in Control 8.18E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 2.68E-09; Z-score: -2.86E+00

Methylation in Case

8.39E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg17044311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 3.35E-09; Z-score: -3.22E+00

Methylation in Case

8.61E-01 (Median) Methylation in Control 9.26E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 6.36E-08; Z-score: -1.99E+00

Methylation in Case

8.56E-01 (Median) Methylation in Control 9.11E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg19604369)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 6.49E-06; Z-score: -1.11E+00

Methylation in Case

9.16E-01 (Median) Methylation in Control 9.27E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg19378330)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.64E-04; Z-score: 3.41E-01

Methylation in Case

1.28E-01 (Median) Methylation in Control 1.08E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 4.10E-03; Z-score: -1.58E-01

Methylation in Case

1.02E-01 (Median) Methylation in Control 1.12E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.33E-02; Z-score: -1.50E+00

Methylation in Case

8.75E-01 (Median) Methylation in Control 8.98E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of ABCC2 in colorectal cancer [ 4 ]

Location

Body (cg07520093)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 2.73E-02; Z-score: -2.90E-01

Methylation in Case

7.10E-02 (Median) Methylation in Control 7.62E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.26E-03; Z-score: -4.21E-01

Methylation in Case

7.48E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg14645545)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.09E+00 Statistic Test p-value: 1.52E-18; Z-score: 3.28E+00

Methylation in Case

4.51E-01 (Median) Methylation in Control 2.16E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg19708984)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.20E+00 Statistic Test p-value: 2.19E-18; Z-score: -4.26E+00

Methylation in Case

3.12E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg10333311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.37E+00 Statistic Test p-value: 7.44E-14; Z-score: -4.94E+00

Methylation in Case

5.00E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg04558907)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.49E+00 Statistic Test p-value: 5.18E-13; Z-score: -3.81E+00

Methylation in Case

4.96E-01 (Median) Methylation in Control 7.41E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg19715414)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.08E+00 Statistic Test p-value: 1.82E-11; Z-score: 3.10E+00

Methylation in Case

3.47E-01 (Median) Methylation in Control 1.67E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 2.29E-09; Z-score: -1.42E+00

Methylation in Case

4.54E-01 (Median) Methylation in Control 6.15E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.48E+00 Statistic Test p-value: 5.80E-08; Z-score: 1.72E+00

Methylation in Case

4.31E-01 (Median) Methylation in Control 2.91E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg16201095)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.75E-07; Z-score: -1.24E+00

Methylation in Case

9.38E-01 (Median) Methylation in Control 9.57E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 6.29E-07; Z-score: -1.62E+00

Methylation in Case

7.12E-01 (Median) Methylation in Control 7.75E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

Body (cg07520093)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.30E+00 Statistic Test p-value: 3.75E-05; Z-score: 7.74E-01

Methylation in Case

6.19E-02 (Median) Methylation in Control 4.76E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of ABCC2 in hepatocellular carcinoma [ 5 ]

Location

3'UTR (cg10841077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.40E-03; Z-score: -5.05E-01

Methylation in Case

8.98E-01 (Median) Methylation in Control 9.07E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in HIV infection [ 6 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 7.08E-04; Z-score: -1.46E+00

Methylation in Case

8.21E-01 (Median) Methylation in Control 8.57E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in HIV infection [ 6 ]

Location

TSS1500 (cg16377144)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 3.75E-03; Z-score: -1.02E+00

Methylation in Case

8.10E-01 (Median) Methylation in Control 8.37E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in HIV infection [ 6 ]

Location

TSS200 (cg09448875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.70E-02; Z-score: -6.37E-01

Methylation in Case

9.44E-01 (Median) Methylation in Control 9.55E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg17044311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.26E+00 Statistic Test p-value: 2.88E-23; Z-score: 3.42E+00

Methylation in Case

8.68E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 5.25E-22; Z-score: 3.19E+00

Methylation in Case

8.63E-01 (Median) Methylation in Control 7.13E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg03381359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 2.52E-18; Z-score: 3.77E+00

Methylation in Case

8.95E-01 (Median) Methylation in Control 7.40E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg19604369)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 3.99E-16; Z-score: 2.21E+00

Methylation in Case

8.78E-01 (Median) Methylation in Control 7.90E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg19378330)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.77E+00 Statistic Test p-value: 5.17E-07; Z-score: 2.08E+00

Methylation in Case

6.80E-02 (Median) Methylation in Control 3.85E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.06E+00 Statistic Test p-value: 1.38E-05; Z-score: 6.75E-01

Methylation in Case

7.69E-01 (Median) Methylation in Control 7.27E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.75E+00 Statistic Test p-value: 4.33E-05; Z-score: 2.23E+00

Methylation in Case

5.89E-02 (Median) Methylation in Control 3.36E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in HIV infection [ 6 ]

Location

Body (cg05403832)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 4.05E-02; Z-score: -5.39E-01

Methylation in Case

6.04E-01 (Median) Methylation in Control 6.25E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of ABCC2 in HIV infection [ 6 ]

Location

3'UTR (cg10841077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 2.09E-04; Z-score: 8.29E-01

Methylation in Case

9.45E-01 (Median) Methylation in Control 9.31E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

TSS1500 (cg00826767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.52E-03; Z-score: 1.22E+00

Methylation in Case

8.42E-01 (Median) Methylation in Control 7.99E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

TSS1500 (cg16377144)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 1.98E-02; Z-score: 1.32E+00

Methylation in Case

7.81E-01 (Median) Methylation in Control 7.43E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

Body (cg08720365)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 3.81E-05; Z-score: -2.85E+00

Methylation in Case

7.92E-01 (Median) Methylation in Control 8.29E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 3.88E-03; Z-score: -2.14E+00

Methylation in Case

7.50E-01 (Median) Methylation in Control 7.90E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.54E-02; Z-score: -1.73E+00

Methylation in Case

8.09E-01 (Median) Methylation in Control 8.36E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in lung adenocarcinoma [ 7 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 3.05E-02; Z-score: -1.69E+00

Methylation in Case

8.44E-01 (Median) Methylation in Control 8.73E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.54E-02; Z-score: -2.16E-01

Methylation in Case

7.84E-01 (Median) Methylation in Control 7.90E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

TSS200 (cg09448875)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 5.11E-03; Z-score: 7.78E-01

Methylation in Case

9.14E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 5.10E-08; Z-score: -1.28E+00

Methylation in Case

7.45E-01 (Median) Methylation in Control 7.64E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg03381359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 5.04E-05; Z-score: -7.06E-01

Methylation in Case

9.28E-01 (Median) Methylation in Control 9.38E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 6.17E-05; Z-score: 7.22E-01

Methylation in Case

8.58E-01 (Median) Methylation in Control 8.18E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg07520093)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 1.75E-03; Z-score: -5.30E-01

Methylation in Case

3.86E-02 (Median) Methylation in Control 4.43E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg08720365)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.24E-03; Z-score: -6.77E-01

Methylation in Case

8.59E-01 (Median) Methylation in Control 8.76E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg25290633)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.49E-03; Z-score: -4.69E-01

Methylation in Case

9.10E-01 (Median) Methylation in Control 9.19E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in papillary thyroid cancer [ 8 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.84E-03; Z-score: -4.76E-01

Methylation in Case

9.11E-01 (Median) Methylation in Control 9.22E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Prostate cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in prostate cancer [ 9 ]

Location

TSS1500 (cg07337598)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 2.65E-02; Z-score: 2.69E+00

Methylation in Case

8.79E-01 (Median) Methylation in Control 8.51E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in prostate cancer [ 9 ]

Location

3'UTR (cg07551022)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 4.47E-02; Z-score: 1.74E+00

Methylation in Case

9.43E-01 (Median) Methylation in Control 9.20E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg16377144)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 9.52E-03; Z-score: -2.64E-01

Methylation in Case

8.51E-01 (Median) Methylation in Control 8.59E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg05914069)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.41E-02; Z-score: -2.01E-01

Methylation in Case

8.53E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 2.47E-02; Z-score: -1.70E-01

Methylation in Case

8.36E-01 (Median) Methylation in Control 8.39E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 3.41E-02; Z-score: -4.79E-02

Methylation in Case

7.58E-01 (Median) Methylation in Control 7.60E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg00706648)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 3.37E-05; Z-score: -1.13E+00

Methylation in Case

7.43E-01 (Median) Methylation in Control 8.39E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg02672229)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 1.99E-04; Z-score: -9.80E-01

Methylation in Case

7.26E-01 (Median) Methylation in Control 7.95E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg03381359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 2.97E-04; Z-score: 5.67E-01

Methylation in Case

9.40E-01 (Median) Methylation in Control 8.98E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg05403832)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.66E+00 Statistic Test p-value: 1.45E-03; Z-score: -8.63E-01

Methylation in Case

1.53E-01 (Median) Methylation in Control 2.55E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg05916255)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.41E+00 Statistic Test p-value: 1.82E-03; Z-score: -4.43E-01

Methylation in Case

4.40E-02 (Median) Methylation in Control 1.06E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg07520093)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.06E+00 Statistic Test p-value: 4.03E-03; Z-score: 1.98E-01

Methylation in Case

3.25E-01 (Median) Methylation in Control 3.06E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg08720365)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 7.81E-03; Z-score: 1.23E+00

Methylation in Case

8.31E-01 (Median) Methylation in Control 7.25E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 2.86E-02; Z-score: 4.19E-01

Methylation in Case

1.04E-01 (Median) Methylation in Control 9.91E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg13617376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 3.76E-02; Z-score: 7.52E-02

Methylation in Case

1.14E-01 (Median) Methylation in Control 1.13E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg14303526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 4.45E-02; Z-score: 4.23E-01

Methylation in Case

8.53E-01 (Median) Methylation in Control 8.28E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of ABCC2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

3'UTR (cg10841077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 4.01E-12; Z-score: -4.80E+00

Methylation in Case

9.03E-01 (Median) Methylation in Control 9.83E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of ABCC2 in panic disorder [ 12 ]

Location

Body (cg12673726)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.76E-01 Statistic Test p-value: 1.52E-02; Z-score: -4.21E-01

Methylation in Case

-4.77E+00 (Median) Methylation in Control -4.65E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of ABCC2 in panic disorder [ 12 ]

Location

Body (cg03381359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.92E-02; Z-score: -5.68E-01

Methylation in Case

1.29E+00 (Median) Methylation in Control 1.51E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant/significant hypermethylation of ABCC2 in liver cancer than that in healthy individual/adjacent tissue

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.47E-09; Fold-change: -0.330225144; Z-score: -1.734613148

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 2.92E-10; Fold-change: -0.327111157; Z-score: -2.331280663
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of ABCC2 in melanocytoma than that in healthy individual

Studied Phenotype

Melanocytoma [ICD-11:2F36.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.16E-11; Fold-change: -0.616986191; Z-score: -33.83827015
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of ABCC2 in melanoma than that in healthy individual

Studied Phenotype

Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.22E-05; Fold-change: -0.430938666; Z-score: -16.04603395
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Colorectal cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

High expression of miR-297 in colorectal cancer (compare to oxaliplatin-resistance counterpart cell) [ 13 ]

Epigenetic Type

microRNA Experiment Method Luciferase reporter assay

Related Molecular Changes

Down regulation of ABCC2 Experiment Method RT-qPCR

miRNA Stemloop ID

miR-297 miRNA Mature ID miR-297

miRNA Sequence

AUGUAUGUGUGCAUGUGCAUG

miRNA Target Type

Direct

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples, Multiple cell lines of human

Additional Notes

miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.

  Ovarian cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

High expression of miR-490-3p in ovarian cancer (compare to multidrug-resistance counterpart cell) [ 14 ]

Epigenetic Type

microRNA Experiment Method Luciferase reporter assay

Related Molecular Changes

Down regulation of ABCC2 Experiment Method Immunohistochemical staining

miRNA Stemloop ID

miR-490 miRNA Mature ID miR-490-3p

miRNA Sequence

CAACCUGGAGGACUCCAUGCUG

miRNA Target Type

Direct

Studied Phenotype

Ovarian cancer [ ICD-11: 2C73]

Experimental Material

Multiple cell lines of human

Additional Notes

miR-490-3p overexpression may increase the sensitivity of ovarian cancer cells to cisplatin by targeting ABCC2.

  Hepatocellular carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Low expression of miR-379 in HCC (compare with rifampicin treatment counterpart cells) [ 15 ]

Epigenetic Type

microRNA Experiment Method Luciferase reporter assay

Related Molecular Changes

Down regulation of ABCC2 Experiment Method Western Blot

miRNA Stemloop ID

miR-379 miRNA Mature ID miR-379-5p

miRNA Sequence

UGGUAGACUAUGGAACGUAGG

miRNA Target Type

Direct

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Human hepatocellular carcinoma cells line (HepG2)

Additional Notes

Down-regulation of ABCC2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379

  Chronic myeloid leukemia

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-205-5p downregulate ABCC2 expression [ 16 ]

Epigenetic Type

microRNA Experiment Method Luciferase reporter assay

Related Molecular Changes

Down regulation of ABCC2 Experiment Method Western Blot

miRNA Stemloop ID

miR-205 miRNA Mature ID miR-205-5p

miRNA Sequence

UCCUUCAUUCCACCGGAGUCUG

miRNA Target Type

Direct

Studied Phenotype

Chronic myeloid leukemia [ ICD-11: 2B33.1]

Experimental Material

Chronic myelocytic leukemia cell line (K562)

Additional Notes

miR-205-5p overexpression may increase the sensitivity of chronic myeloid leukemia cells to imatinib by targeting ABCC2.

  Unclear Phenotype

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-490 directly targets ABCC2 [ 14 ]

Epigenetic Type

microRNA Experiment Method Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot

miRNA Stemloop ID

miR-490 miRNA Mature ID miR-490-3p

miRNA Sequence

CAACCUGGAGGACUCCAUGCUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
6 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
7 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
8 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
9 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
10 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
11 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
12 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
13 miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. Biochem J. 2012 Sep 1;446(2):291-300.
14 MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2. Am J Transl Res. 2017 Mar 15;9(3):1127-1138. eCollection 2017.
15 Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol. 2011 Aug;80(2):314-20.
16 LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p. Am J Cancer Res. 2017 Aug 1;7(8):1704-1713. eCollection 2017.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.